Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.
UK-based William Ransom & Son has been advised to voluntarily
recall certain products following a false contamination scare at
its Witham, Essex, facility.
University of Texas at Arlington (UTA) spin-out has exclusively
licensed plasma coating technology that could improve the
controlled release of drugs and the biocompatibility of medical
implants.
Italy's Defiante Farmaceutica is in negotiations with BioDelivery
Sciences International for the development of a new formulation of
aspirin that could cut the risks of side effects with the
painkiller.